WZ
Therapeutic Areas
Vigonvita Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VV116 (Deuremidevir Hydrobromide) Tablets | COVID-19 | Approved |
| VV116 Dry Suspension | Respiratory Syncytial Virus (RSV) Infection | Phase 2 |
| TPN171 (Simenafil hydrochloride) Tablets | Erectile Dysfunction | Approved |
| LV232 | Depression | Phase 2 |
| VV119 | Schizophrenia | Phase 1 |
| VV261 | Fever with Thrombocytopenia Syndrome (Novel Bunyavirus) | Phase 1 |
| TPN102 | Epilepsy | Phase 1 |